Medtronic, the global leader in medical technology, announced the launch of InPen™ integrated with real-time Guardian Connect™ CGM data. InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI). This integrated system now provides real-time glucose readings alongside insulin dose information, giving users everything they need to manage their diabetes in one view. Rather than switching between apps, users can see all their data in real-time, in one picture — making it easier to make smarter dosing decisions to manage their sugar levels. News Release